Sofosbuvir，Velpatasvir and Voxilaprevir

Indication: 用于治疗既往接受过含直接抗病毒药物（DAA）方案、无肝硬化或伴代偿性肝硬化（Child-Pugh A）的成人慢性丙型肝炎病毒（HCV）感染

Drug Development Updates

Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.